Alterity Therapeutics Limited (NASDAQ: ATHE) is 105.13% higher on its value in year-to-date trading and has touched a low of $0.28 and a high of $2.35 in the current 52-week trading range. The ATHE stock was last observed hovering at around $1.60 in the recent trading session, with the current loss setting it -0.1% off its average median price target of $4.00 for the next 12 months. It is also 62.5% off the consensus price target high of $4.00 offered by analysts, but current levels are 62.5% higher than the price target low of $4.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
At last check, trading at $1.50, the stock is 101.92% and 121.60% above its SMA20 and SMA50 respectively. However, with a current trading volume of 0.54 million and changing -6.25% at the moment leaves the stock 86.36% off its SMA200. ATHE registered 31.15% gain for a year compared to 6-month loss of 107.79%. The firm has a 50-day simple moving average (SMA 50) of $0.6885 and a 200-day simple moving average (SMA200) of $0.6899.
The stock witnessed a 180.65% gain in the last 1 month and extending the period to 3 months gives it a 125.35%, and is 173.50% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 28.72% over the week and 12.56% over the month.
Distance from 52-week low is 435.71% and -36.17% from its 52-week high.
Alterity Therapeutics Limited (ATHE) Analyst Forecasts
Alterity Therapeutics Limited quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to shrink by -29.30% this year.
Alterity Therapeutics Limited (ATHE) Top Institutional Holders
9 institutions hold shares in Alterity Therapeutics Limited (ATHE), with institutional investors hold 1.96% of the company’s shares. The shares outstanding are 14.47M, and float is at 9.75M with Short Float at 0.09%. Institutions hold 1.96% of the Float.
The top institutional shareholder in the company is Morgan Stanley with over 0.28 million shares valued at $0.17 million. The investor’s holdings represent 1.64% of the ATHE Shares outstanding. As of Mar 30, 2020, the second largest holder is Geode Capital Management, LLC with 12128.0 shares valued at $7276.0 to account for 0.07% of the shares outstanding. The other top investors are UBS Group AG which holds 3077.0 shares representing 0.02% and valued at over $1846.0, while Wells Fargo & Company holds 0.01% of the shares totaling 2500.0 with a market value of $1500.0.